“To realize the American Dream, the most important thing to understand first is that it belongs to everybody who chooses to believe. It’s a human dream. A faith in something one cannot see at first - but that if you understand and work very hard - it is possible.”

The last eight months have made history in ways few could imagine.

And the data is flush with the confusion of emotions and opinions.

But maybe it’s all for good reason.

Pfizer has released some pretty good news. A vaccine! Delivered in record time and just before the cold winds of Winter.

Earnings beat rates are setting records. The latest data shows that the collective earnings number continues to increase week over week, as it has done in all but two weeks since April. Interestingly the 2022 number (something analysts will be assuming by about August of 2021) is already approaching $200/share:

Note the surges in all projected data points just since the beginning of October about five weeks ago.

The analysts will be behind this surge, recovery, and reshaping of margins across the landscape for years!

That's good news for investors.

And it also suggests we should be praying for a correction as it just might be the last one we see for a while.

The Strength?

Tech, tech, and tech.

It is abundantly clear where the growth is:

As of Friday's earnings data the chart above shows the powerful drivers in place. 

And the images below give you a sense of how that is set to continue as they barely got dinged after all this mess in 2020:

Now, check the last column in the second image above. It shows beat rates in both earnings and revenues of over 90% in Q3 of 2020. 

Once again, pray for a correction.